Brain-computer interfaces represent a revolutionary intersection of neuroscience and technology. They allow direct communication between the brain and external devices, bypassing traditional pathways.
The Global Brain Computer Interface Market is estimated to be valued at USD 2.40 Bn in 2025 and is expected to reach USD 6.16 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 14.4% from ...
Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...
US brain-computer-interface startup Paradromics is quickly establishing itself as a major player in the neural-device space, ...
Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.
The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.
The device transmitted brain activity data wirelessly from a living animal for over a year. Read more at straitstimes.com.
U.S. neurotechnology company Paradromics is launching a clinical trial to restore lost voices using human brain signals.
Morning Overview on MSN
China claims a monkey brain upload to a supercomputer
China’s latest neuromorphic project has pushed a once speculative idea into the realm of claimed reality: a monkey’s brain ...
The Global Spinal Implants And Surgery Devices Market Size projected to grow at a CAGR of 4.3% from 2026 to 2032, according ...
AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) was approved in the U.S. for the treatment of adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback